Erectile dysfunction drug makers expand despite consumer spending slump

Expansion plans for erectile dysfunction (ED) drug makers in Korea are running smoothly, unobstructed by the nation's prolonged slump in consumer spending.

The nations' top ED brands Pfizer Korea's Viagra, Bayer-GSK's Levitra and Lilly's Cialis, are continuing the expansion spree of a sector whose market value is forecast to jump in the years to come, as about 10-15 percent of Korean patie...